resources

Media Coverage
November 29th, 2022

Poolbeg Pharma reaches R&D milestone as partner CytoReason completes AI influenza disease model

Poolbeg Pharma reaches R&D milestone as partner CytoReason completes AI influenza disease model
Media Coverage
September 22nd, 2022

CytoReason, Pfizer ink $110M, 5-year extension of AI-powered drug development deal

Media Coverage
June 24th, 2022

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Media Coverage
May 31st, 2022

Bringing Data to Life – Joint Webinar about CytoReason-Ferring Collaboration

Media Coverage
April 13th, 2022

CytoReason expands reach in Asia, leveraging ML in drug development for Korean drugmakers

Media Coverage
April 12th, 2022

Israel’s CytoReason, S. Korea’s Helixrus partner on machine learning for drug development

Bring your data to life